Agios Pharma (AGIO) Stock Statistics & Valuation Metrics

Agios Pharma has a market cap or net worth of $2.00B. The enterprise value is $1.48B.

Agios Pharma has 57,915,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Agios Pharma’s return on equity (ROE) is 0.44 and return on invested capital (ROIC) is -24.99%.

The current PE Ratio of Agios Pharma is 2.77. Agios Pharma’s PEG ratio is 0.20.

In the last 12 months, Agios Pharma had revenue of 36.50M and earned 673.73M in profits. Earnings per share was 11.86.

In the last 12 months, operating cash flow was -401.46M and capital expenditures -2.31M, giving a free cash flow of -403.77M billion.

Agios Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Agios Pharma upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.

Agios Pharma as a current ratio of 11.90, with Debt / Equity ratio of 7.78%

In the past 12 months, Agios Pharma has paid 44.24M in taxes.

Agios Pharma EV to EBITDA ratio is -4.34, with an EV/FCF ratio of -4.72.

Agios Pharma has $893.38M in cash and marketable securities with $52.94M in debt, giving a net cash position of -$840.43M billion.

Gross margin is 88.03%, with operating margin of -1166.47%, and net profit margin of 1845.92%.

The average price target for Agios Pharma is $57.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy